Shopping Cart

Remove All

Your shopping cart is currently empty

Peptide5 acetate

Select Batch

Purity:98.88%

Resource Download

COA HPLC MS

Peptide5 acetate

Catalog No. T36851L

Peptide5 acetate reduces animal swelling, astrogliosis, and neuronal cell death after spinal cord injury. Peptide5 acetate significantly reduces the degree of spinal cord injury (SCI) in a rodent ex vivo model.

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Pack Size	Price	Availability
1 mg	$195	In Stock
5 mg	$437	In Stock
10 mg	$646	In Stock
25 mg	$987	In Stock
50 mg	$1,380	In Stock
100 mg	$1,860	In Stock
500 mg	$3,720	In Stock

Bulk & Custom

Add to Cart

Questions

Related Compound Libraries of "Peptide5 acetate"

Product Introduction

Bioactivity

Description	Peptide5 acetate reduces animal swelling, astrogliosis, and neuronal cell death after spinal cord injury. Peptide5 acetate significantly reduces the degree of spinal cord injury (SCI) in a rodent ex vivo model.
In vitro	Treatment with Peptide5 acetate reduced both the level of Cx43 and the number of glial fibrillary acidic protein (GFAP)-positive astrocytes, and at the same time reduces the loss of NeuN- and SMI-32–positive neurons in a concentration- and time-dependent manner. Peptide5 acetate produces a more significant reduction in swelling[2].
In vivo	Peptide5 acetate can be used in the treatment of traumatic spinal cord injured rats[2].

Chemical Properties

Cas No.

Storage & Solubility Information

Storage	store at low temperature,store under nitrogen,keep away from moisture Powder: -20°C for 3 years \| In solvent: -80°C for 1 year
Solubility Information	DMSO: 50.00mg/ml

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:

For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments

A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent

DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。

Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO TargetMol | reagent

(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.

Preparation method for in vivo formula: Take 50 μL DMSO TargetMol | reagent

main solution, add 300 μLPEG300 TargetMol | reagent

mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O TargetMol | reagent

mix well and clarify

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc